[MYGN] QoQ Quarter Result on 30-Jun-2020 [#Q2]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
13-Aug-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- 51.91%
YoY- -1,219.05%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Revenue 173,100 154,600 145,200 93,200 164,000 195,100 186,300 -4.77%
PBT -49,600 -55,700 -43,700 -58,500 -131,100 -11,400 -22,300 70.30%
Tax -10,100 -11,500 -28,500 -3,000 -15,900 -3,100 -1,700 227.67%
NP -39,500 -44,200 -15,200 -55,400 -115,200 -8,300 -20,600 54.28%
Tax Rate - - - - - - - -
Total Cost 212,600 198,800 160,400 148,600 279,200 203,400 206,900 1.82%
Ratio Analysis
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
NP Margin -22.82 -28.59 -10.47 -59.44 -70.24 -4.25 -11.06 62.00%
Per Share
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
EPS -0.52 -0.59 -0.20 -0.74 -1.55 -0.11 -0.28 51.03%
EPS Diluted -0.52 -0.59 -0.20 -0.74 -1.55 -0.11 -0.28 51.03%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.